Reporting Manager
ARCH Venture Fund IX, L.P.
Symbol
OMIC
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 17:05:01 UTC
Date of event
21 Feb 2025

Sponsored

Quoteable Key Fact

"ARCH Venture Fund IX, L.P. disclosed 0% ownership in Singular Genomics Systems, Inc. Common Stock par value $0.0001 per share (OMIC) on 21 Feb 2025."

Quick Takeaways

  • ARCH Venture Fund IX, L.P. filed SCHEDULE 13G/A for Singular Genomics Systems, Inc. Common Stock par value $0.0001 per share (OMIC).
  • Disclosed ownership: 0%.
  • Date of event: 21 Feb 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 15 May 2025, 17:05.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ARCH Venture Fund IX, L.P. 0% 0 0 0 ARCH Venture Partners IX, L.P. its General Partner
ARCH Venture Partners IX, L.P. 0% 0 0 0 ARCH Venture Partners IX, LLC its General Partner
ARCH Venture Partners IX, LLC 0% 0 0 0 /s/ Mark McDonnell * Mark McDonnell, as Attorney-in-Fact for Keith Crandell, Managing Director
Keith Crandell 0% 0 0 0 /s/ Mark McDonnell * Mark McDonnell, as Attorney-in-Fact for Keith Crandell
Clinton Bybee 0% 0 0 0 /s/ Mark McDonnell * Mark McDonnell, as Attorney-in-Fact for Clinton Bybee
Robert Nelsen 0% 0 0 0 /s/ Mark McDonnell * Mark McDonnell, as Attorney-in-Fact for Robert Nelsen